ABCG2 and glioblastoma: Recently, symmetric bis-chalcones were demonstrated to be potent inhibitors of the breast cancer resistance protein (BCRP/ABCG2); however, the anti-cancer effects of bis-chalcones have not been investigated in GBM [23].